Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort

• Glavni autori: Nathan Vidal (Autor), Paul Roux (Autor), Mathieu Urbach (Autor), Cristobal Belmonte (Autor), Laurent Boyer (Autor), Delphine Capdevielle (Autor), Julie Clauss-Kobayashi (Autor), Thierry D'Amato (Autor), Romane Dassing (Autor), Caroline Dubertret (Autor), Julien Dubreucq (Autor), Guillaume Fond (Autor), Roxana-Mihaela Honciuc (Autor), Sylvain Leignier (Autor), Pierre-Michel Llorca (Autor), Jasmina Mallet (Autor), David Misdrahi (Autor), Baptiste Pignon (Autor), Romain Rey (Autor), Franck Schürhoff (Autor), Arnaud Tessier (Autor), the FACE-SZ (FondaMental Academic Centers of Expertise-Schizophrenia) (Autor), Christine Passerieux (Autor), Eric Brunet-Gouet (Autor), B. Aouizerate (Autor), V. Barteau (Autor), S. Bensalem (Autor), F. Berna (Autor), O. Blanc (Autor), E. Bourguignon (Autor), L. Boyer (Autor), D. CapdevielleI. Chéreau (Autor), G. Chesnoy-Servanin (Autor), T. D'Amato (Autor), A. Deloge (Autor), H. Denizot (Autor), JM. Dorey (Autor), C. Dubertret (Autor), J. Dubreucq (Autor), S. Esselin (Autor), C. Faget (Autor), C. Fluttaz (Autor), G. Fond (Autor), F. Gabayet (Autor), O. Godin (Autor), E. Haffen (Autor), RM. Honciuc (Autor), M. Jarroir (Autor), D. Lacelle (Autor), C. Lançon (Autor), H. Laouamri (Autor), M. Leboyer (Autor), PM Llorca (Autor), J. Mallet (Autor), E. Metairie (Autor), D. Misdrahi (Autor), C. Passerieux (Autor), J. Petrucci (Autor), P. Peri (Autor), B. Pignon (Autor), S. Pires (Autor), C. Portalier (Autor), R. Rey (Autor), C. Roman (Autor), F. Schürhoff (Autor), K. Souryis (Autor), A. Szöke (Autor), M. Urbach (Autor), F. Vaillant (Autor), A (Autor), Vehier (Autor), P. Vidailhet (Autor), E. Vilà (Autor), G. Wahiche (Autor), H. Yazbek (Autor), A. Zinetti-Bertschy (Autor)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

AimThe anticholinergic properties of medications are associated with poorer cognitive performance in schizophrenia. Numerous scales have been developed to assess anticholinergic burden and yet, there is no consensus indicating which anticholinergic burden scale is more relevant for patients with sch...